Foghorn Therapeutics Inc. (FHTX) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 8 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for FHTX is $11.67, representing a +140.6% upside from the current price of $4.85. Price targets range from a low of $11.00 to a high of $12.00.
